{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:44:33Z","timestamp":1792226673585,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1053\/j.akdh.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:03:28Z","timestamp":1722243808000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Minimal Change Disease"],"prefix":"10.1053","volume":"31","author":[{"given":"Alexis C.","family":"Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisha L.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-1022","authenticated-orcid":false,"given":"Harish","family":"Seethapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.akdh.2024.02.002_bib1","series-title":"Comprehensive Pediatric Nephrology","first-page":"205","article-title":"Chapter 12 - nephrotic syndrome","author":"Gbadegesin","year":"2008"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.002_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"30","key":"10.1053\/j.akdh.2024.02.002_bib3","first-page":"289","article-title":"Reports of medical cases: Selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy","volume":"15","author":"Bright","year":"1831","journal-title":"Med Chir Rev"},{"issue":"101","key":"10.1053\/j.akdh.2024.02.002_bib4","first-page":"262","article-title":"Observations on the variety of dropsy which depends on diseased kidney","volume":"32","author":"Christison","year":"1829","journal-title":"Edinb Med Surg J"},{"key":"10.1053\/j.akdh.2024.02.002_bib5","first-page":"194","article-title":"XVII. On the presence of the red matter and serum of blood in the urine of dropsy, which has not originated from scarlet fever","volume":"3","author":"Wells","year":"1812","journal-title":"Tr Soc Improv Med Clin Knowl"},{"key":"10.1053\/j.akdh.2024.02.002_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fped.2016.00056","article-title":"History of nephrotic syndrome and evolution of its treatment","volume":"4","author":"Pal","year":"2016","journal-title":"Front Pediatr"},{"issue":"Suppl","key":"10.1053\/j.akdh.2024.02.002_bib7","first-page":"S5","article-title":"Five hundred years of the nephrotic syndrome: 1484-1984","volume":"54","author":"Cameron","year":"1985","journal-title":"Ulster Med J"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.002_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-012-1254-7","article-title":"Historical milestones in renal pathology","volume":"461","author":"Weening","year":"2012","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1053\/j.akdh.2024.02.002_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"74","key":"10.1053\/j.akdh.2024.02.002_bib10","first-page":"603","article-title":"Proteinuria caused by transfusion of blood from nephrotic to non-nephrotic individuals","volume":"45","author":"Gentili","year":"1954","journal-title":"Minerva Med"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.002_bib11","first-page":"255","article-title":"Transmission of nephrotic syndrome to two neonates. Spontaneous regression","volume":"20","author":"Lagrue","year":"1991","journal-title":"Presse Medicale Paris Fr 1983"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.002_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1056\/NEJM200102013440517","article-title":"Transmission of glomerular permeability factor from a mother to her child","volume":"344","author":"Kemper","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.002_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000183647","article-title":"Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection","volume":"42","author":"Lin","year":"1986","journal-title":"Nephron"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.002_bib14","first-page":"479","article-title":"Prednisone-induced alterations of circulating human lymphocyte subsets","volume":"101","author":"Slade","year":"1983","journal-title":"J Lab Clin Med"},{"issue":"12","key":"10.1053\/j.akdh.2024.02.002_bib15","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2024.02.002_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.736341","article-title":"B lymphocyte subsets in children with steroid-sensitive nephrotic syndrome: a Longitudinal study","volume":"9","author":"Ling","year":"2021","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.002_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00467-018-4095-z","article-title":"B cell phenotype in pediatric idiopathic nephrotic syndrome","volume":"34","author":"Colucci","year":"2019","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"10.1053\/j.akdh.2024.02.002_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2020.08.002","article-title":"Measles immunity and immunosuppression","volume":"46","author":"Griffin","year":"2021","journal-title":"Curr Opin Virol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.002_bib19","first-page":"3603","article-title":"Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation","volume":"187","author":"Karnell","year":"2011","journal-title":"J Immunol Baltim Md 1950"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.002_bib20","first-page":"2453","article-title":"Suppression of human B lymphocyte function by cyclophosphamide","volume":"128","author":"Cupps","year":"1982","journal-title":"J Immunol Baltim Md 1950"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.002_bib21","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"9950","key":"10.1053\/j.akdh.2024.02.002_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.002_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00467-020-04811-0","article-title":"A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome","volume":"36","author":"Dossier","year":"2021","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.002_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of Autoantibodies targeting nephrin in minimal change disease Supports a Novel Autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol JASN"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.002_bib25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2024.02.002_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2215\/CJN.08090719","article-title":"NSAIDs and nephrotic syndrome","volume":"14","author":"M\u00e9rida","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.002_bib27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2215\/CJN.00860115","article-title":"Drug-induced glomerular disease: direct cellular injury","volume":"10","author":"Markowitz","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 6","key":"10.1053\/j.akdh.2024.02.002_bib28","first-page":"vi52","article-title":"Secondary minimal change disease","volume":"18","author":"Glassock","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.002_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ekir.2020.10.002","article-title":"A Systematic review of immune checkpoint inhibitor-associated glomerular disease","volume":"6","author":"Kitchlu","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.002_bib31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ndt\/gfl808","article-title":"Minimal-change nephropathy and chronic hepatitis C infection: coincidental or associated?","volume":"22","author":"Aoyama","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2024.02.002_bib32","article-title":"Minimal-change disease Secondary to Borrelia burgdorferi infection","volume":"2012","author":"Kwiatkowska","year":"2012","journal-title":"Case Rep Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.002_bib33","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2009.03.019","article-title":"Idiopathic nephrotic syndrome and atopy: is there a common link?","volume":"54","author":"Abdel-Hafez","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.002_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5414\/CNP65203","article-title":"Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?","volume":"65","author":"Westhoff","year":"2006","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.002_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5414\/CNP57120","article-title":"Minimal change disease in systemic lupus erythematosus","volume":"57","author":"Dube","year":"2002","journal-title":"Clin Nephrol"},{"issue":"28","key":"10.1053\/j.akdh.2024.02.002_bib36","first-page":"574","article-title":"Updated recommendations for Use of VariZIG \u2014 United States, 2013","volume":"62","author":"Marin","year":"2013","journal-title":"Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1053\/j.akdh.2024.02.002_bib37","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00467-015-3241-0","article-title":"The non-immunosuppressive management of childhood nephrotic syndrome","volume":"31","author":"McCaffrey","year":"2016","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"5","key":"10.1053\/j.akdh.2024.02.002_bib38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2215\/CJN.04390808","article-title":"Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study","volume":"4","author":"Kapur","year":"2009","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"3","key":"10.1053\/j.akdh.2024.02.002_bib39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.002_bib40","article-title":"Human albumin infusion for treating oedema in people with nephrotic syndrome","volume":"7","author":"Ho","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.002_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00467-013-2525-5","article-title":"Venous thromboembolism in pediatric nephrotic syndrome","volume":"29","author":"Kerlin","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.002_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/20009666.2019.1688125","article-title":"Adult minimal change disease with acute kidney injury: a case report and literature review","volume":"9","author":"Nicholas","year":"2019","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"7","key":"10.1053\/j.akdh.2024.02.002_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00467-003-1170-9","article-title":"Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook","volume":"18","author":"Vester","year":"2003","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"11","key":"10.1053\/j.akdh.2024.02.002_bib44","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","article-title":"Long-term outcome of adult-onset minimal-change nephropathy","volume":"11","author":"Mak","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.002_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00467-021-04983-3","article-title":"Update on the treatment of steroid-sensitive nephrotic syndrome","volume":"37","author":"Zotta","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2024.02.002_bib46","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","article-title":"Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome","volume":"23","author":"Dorresteijn","year":"2008","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.002_bib47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/FTD.0000000000000258","article-title":"Mycophenolate mofetil therapy in children with idiopathic nephrotic syndrome: does therapeutic drug monitoring make a difference?","volume":"38","author":"Hackl","year":"2016","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.1053\/j.akdh.2024.02.002_bib48","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J Am Soc Nephrol JASN"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.002_bib49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10928-009-9136-6","article-title":"Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients","volume":"36","author":"de Winter","year":"2009","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"11","key":"10.1053\/j.akdh.2024.02.002_bib50","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","article-title":"Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome","volume":"27","author":"Wang","year":"2012","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.002_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000357355","article-title":"Second-line immunosuppressive treatment of childhood nephrotic syndrome: a Single-center experience","volume":"4","author":"Kim","year":"2014","journal-title":"Nephron Extra"},{"issue":"1","key":"10.1053\/j.akdh.2024.02.002_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nep.12537","article-title":"Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome","volume":"21","author":"Wang","year":"2016","journal-title":"Nephrol Carlton Vic"},{"issue":"6","key":"10.1053\/j.akdh.2024.02.002_bib53","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00467-020-04609-0","article-title":"Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen","volume":"36","author":"Yu-Hin Chan","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.02.002_bib54","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ckj\/sfy067","article-title":"Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome","volume":"12","author":"Cortazar","year":"2018","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1053\/j.akdh.2024.02.002_bib55","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2215\/CJN.12571213","article-title":"De novo glomerular diseases after renal transplantation","volume":"9","author":"Ponticelli","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2024.02.002_bib56","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.transproceed.2003.10.056","article-title":"Recurrent minimal change disease post-allograft renal transplant","volume":"35","author":"Jan","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1053\/j.akdh.2024.02.002_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaut.2017.12.014","article-title":"Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice","volume":"89","author":"Jamin","year":"2018","journal-title":"J Autoimmun"},{"issue":"18","key":"10.1053\/j.akdh.2024.02.002_bib58","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.21037\/atm-21-3988","article-title":"The important roles and molecular mechanisms of annexin A2 autoantibody in children with nephrotic syndrome","volume":"9","author":"Ye","year":"2021","journal-title":"Ann Transl Med"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T05:06:09Z","timestamp":1722488769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813924000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2949813924000405"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.02.002","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal Change Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}